Organ Failure, Multiple
23
5
7
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
9%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (23)
Sepsis in the ICU-II
Controlled Terminal Reperfusion With Cold Preservation Solution in the cDCD III Donor
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
ICU Background Early Awareness for Critical deterioratiON
Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs
Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Electronic Archive of Internal Medicine for the Treatment of Severe Organ Failure and Liver Transplantation-MITIGO
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
The Val-CARD Trial
The PRE-OP ENERGY Trial
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
DNA Damage in Critically Ill COVID-19 Patients
Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.
Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery
PROOF: Pancreatitis-associated Risk Of Organ Failure
Heterogeneity of Critical Illness: a Cohort Study
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.